Literature DB >> 32501157

Test-retest variability and reference region-based quantification of 18F-BCPP-EF for imaging mitochondrial complex I in the human brain.

Ayla Mansur1,2,3, Eugenii A Rabiner1,3,4, Hideo Tsukada3,5, Robert A Comley3,6, Yvonne Lewis1,3, Mickael Huiban1,3, Jan Passchier1,2,3, Roger N Gunn1,2,3.   

Abstract

Mitochondrial complex I (MC-I) is an essential regulator of brain bioenergetics and can be quantified in the brain using PET radioligand 18F-BCPP-EF. Here we evaluate the test-retest reproducibility of 18F-BCPP-EF in humans, and assess the use of a non-invasive quantification method (standardised uptake value ratio - SUVR). Thirty healthy volunteers had a 90-min dynamic 18F-BCPP-EF scan with arterial blood sampling, five of which received a second scan to be included in the test-retest analysis. Time-activity curves (TAC) were analysed using multilinear analysis 1 (MA1) and the two-tissue compartment model (2TC) to estimate volumes of distribution (VT). Regional SUVR-1 values were calculated from the 70 to 90-min TAC data using the centrum semiovale as a pseudo reference region, and compared to kinetic analysis-derived outcome measures. The mean absolute test-retest variability of VT ranged from 12% to 18% across regions. Both DVR-1and SUVR-1 had improved test-retest variability in the range 2%-7%. SUVR-1 was highly correlated with DVR-1 (r2 = 0.97, n = 30). In conclusion, 18F-BCPP-EF has suitable test-retest reproducibility and can be used to quantify MC-I in clinical studies.

Entities:  

Keywords:  Brain imaging; MC-I; kinetic modelling; neurodegeneration; positron emission tomography

Year:  2020        PMID: 32501157      PMCID: PMC7983506          DOI: 10.1177/0271678X20928149

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  20 in total

1.  Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region.

Authors:  Pontus Plavén-Sigray; Martin Schain; Francesca Zanderigo; Eugenii A Rabiner; Roger N Gunn; R Todd Ogden; Simon Cervenka
Journal:  Neuroimage       Date:  2018-11-27       Impact factor: 6.556

2.  Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults.

Authors:  Günther Grabner; Andrew L Janke; Marc M Budge; David Smith; Jens Pruessner; D Louis Collins
Journal:  Med Image Comput Comput Assist Interv       Date:  2006

3.  Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited.

Authors:  Vincent J Cunningham; Eugenii A Rabiner; Mark Slifstein; Marc Laruelle; Roger N Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-09       Impact factor: 6.200

4.  Evaluating the gray and white matter energy budgets of human brain function.

Authors:  Yuguo Yu; Peter Herman; Douglas L Rothman; Divyansh Agarwal; Fahmeed Hyder
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-07       Impact factor: 6.200

5.  The energetics of CNS white matter.

Authors:  Julia J Harris; David Attwell
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

6.  Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.

Authors:  N A Lassen; P A Bartenstein; A A Lammertsma; M C Prevett; D R Turton; S K Luthra; S Osman; P M Bloomfield; T Jones; P N Patsalos
Journal:  J Cereb Blood Flow Metab       Date:  1995-01       Impact factor: 6.200

7.  Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET.

Authors:  Hideo Tsukada; Hiroyuki Ohba; Masakatsu Kanazawa; Takeharu Kakiuchi; Norihiro Harada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-21       Impact factor: 9.236

8.  Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy.

Authors:  Andri C Tziortzi; Graham E Searle; Sofia Tzimopoulou; Cristian Salinas; John D Beaver; Mark Jenkinson; Marc Laruelle; Eugenii A Rabiner; Roger N Gunn
Journal:  Neuroimage       Date:  2010-06-30       Impact factor: 6.556

9.  Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.

Authors:  Norihiro Harada; Shingo Nishiyama; Masakatsu Kanazawa; Hideo Tsukada
Journal:  J Labelled Comp Radiopharm       Date:  2013-07-30       Impact factor: 1.921

10.  Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.

Authors:  Rachel Barker; Emma L Ashby; Dannielle Wellington; Vivienne M Barrow; Jennifer C Palmer; Patrick G Kehoe; Margaret M Esiri; Seth Love
Journal:  Brain       Date:  2014-03-10       Impact factor: 13.501

View more
  4 in total

Review 1.  Positron emission tomography in multiple sclerosis - straight to the target.

Authors:  Benedetta Bodini; Matteo Tonietto; Laura Airas; Bruno Stankoff
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

Review 2.  The role of neuroimaging in Parkinson's disease.

Authors:  Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth
Journal:  J Neurochem       Date:  2021-10-03       Impact factor: 5.546

Review 3.  Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases.

Authors:  Heather Wilson; Marios Politis; Eugenii A Rabiner; Lefkos T Middleton
Journal:  Cells       Date:  2020-12-02       Impact factor: 6.600

Review 4.  Neuroimaging Methods to Map In Vivo Changes of OXPHOS and Oxidative Stress in Neurodegenerative Disorders.

Authors:  Jannik Prasuhn; Liesa Kunert; Norbert Brüggemann
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.